Virtual reality holograms have power to transform medical education

Man with plastic black device over eyes

In just a couple years virtual reality holograms could become a real part of medical education, according to a Case Western Reserve University leader.

The Cleveland institution is experimenting with Microsoft’s HoloLens to see how it could be used in the classroom, Pamela Davis, M.D., Ph.D., dean of the medical school, tells MedCity News.

She says it’s “arguably the most exciting technology in medical education on the horizon today.”

Free Daily Newsletter

Like this story? Subscribe to FierceHealthcare!

The healthcare sector remains in flux as policy, regulation, technology and trends shape the market. FierceHealthcare subscribers rely on our suite of newsletters as their must-read source for the latest news, analysis and data impacting their world. Sign up today to get healthcare news and updates delivered to your inbox and read on the go.

The university currently is just testing out the tech, but will start to use it in practice once evaluations wrap up. Davis says she hopes by 2019--when the medical school moves to a new campus--students will be working with HoloLens.

The tool will expand medical education because it will allow students to examine a beating heart hologram or watch the process to insert a catheter from educators miles away, she says.

“It’s an incredible pedagogical tool that capitalizes on how millennials learn,” Davis adds. “It offers the best illustrations of what we want to teach and we can perfect those illustrations in three dimensions, perfect the movements of the heart and everything we want to show.”

Virtual reality is already having an impact on the industry; in April the first surgery was streamed online using the technology. People around the world were able to watch the Royal London Hospital-based operation using Google Cardboard VR glasses paired with the VRinOR app.

- here's the MedCity News article 

Suggested Articles

While UPS didn't say which vaccine it would be using in the project, Reuters confirmed with pharma giant Merck that it is looking at participating.

Too many barriers block medications that treat opioid use disorders.

A missed, failed, or wrong diagnosis is the top allegation in malpractice claims involving children ages one month to 17 years, an analysis found.